Similar Items: Performance of host blood transcriptomic signatures for TB diagnosis and monitoring TB treatment
- Biomarkers and cell phenotypes in TB patients with minimal or persisting lung inflammation post-anti-TB treatment and ex-vivo atorvastatin immunomodulatory effects on M. tuberculosis-infected PBMC
- Evaluation of the potential of Mycobacterium tuberculosis antigen-specific host biomarkers detected in QuantiFERON® TB GOLD Plus supernatants in the diagnosis of TB disease
- Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
- Patient experiences and perceptions of non-compliance with TB treatment
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Strategies for optimising TB-HIV co-treatment in children and adolescents with drug-susceptible tuberculosis on rifampicin-based standard regimens